Medical News

RSS

First Edition: September 3, 2013

Today's headlines include reports about interest in and action surrounding state health exchange call centers.

3 Sep 2013

Apitope successfully completes ATX-MS-1467 Phase I trial in relapsing MS patients with positive results

Apitope, the drug discovery and development company focused on treating the underlying cause of autoimmune diseases, today announced completion with positive results of its second Phase I clinical trial of ATX-MS-1467.

3 Sep 2013

Prana's PBT2 drug recognised as one of the most promising treatments under development

Prana Biotechnology, a leading global developer of first-in-class treatments for neurodegenerative disease, is pleased to announce Elsevier Business Intelligence has named clinical drug PBT2 as one of the Top 10 Neuroscience Projects to Watch.

3 Sep 2013

Imaxio's pro-immunogenic technology used in tuberculosis vaccine phase I clinical study

Imaxio, a biopharmaceutical company specializing in vaccines and genomics, announces today that IMX313, its proprietary pro-immunogenic technology, has been administered for the first time in humans in a tuberculosis vaccine phase I clinical study. The trial is being conducted by the Jenner Institute at Oxford University, England.

3 Sep 2013

New NPS MedicineWise educational program highlights medicine-related adverse events in older people

A new NPS MedicineWise health professional educational program launched today looks at the complex issues that contribute to the disproportionate number of medicine-related adverse events and hospital admissions experienced by older Australians.

3 Sep 2013

Renin inhibitor aliskiren not effective in slowing progression of coronary atherosclerosis

Among patients with prehypertension and coronary artery disease, use of the renin (an enzyme secreted by the kidneys) inhibitor aliskiren, compared with placebo, did not result in improvement or slowing in the progression of coronary atherosclerosis, according to a study published by JAMA.

3 Sep 2013

The Learning Habit Study examines family routines and child's ability to learn

Parents with children in grades K-12 are being asked to take part in The Learning Habit Study, an online research study that will examine how media use, family routines and parenting style impact a child's ability to learn.

3 Sep 2013

Elsevier publishes position statement by EMAS in journal Maturitas on the topic of late parenthood

Elsevier, a world-leading provider of scientific, technical and medical information products and services, today announced the publication of a position statement by the European Menopause and Andropause Society (EMAS) in the journal Maturitas on the topic of late parenthood.

3 Sep 2013

Research shows how mucosal surfaces in body respond to C. albicans to prevent damage

Candida albicans is a common fungus found living in, and on, many parts of the human body. Usually this species causes no harm to humans unless it can breach the body's immune defences, where can lead to serious illness or death.

3 Sep 2013

Trypophobia: The most common phobia may occur as result of specific visual feature

Does the sight of soap bubbles, aerated chocolate or a lotus flower seed pod bring you out in a cold sweat and make you feel panicky? If so, you could be a sufferer of one of the most common phobias you have never heard of - trypophobia, or the fear of holes.

3 Sep 2013

Findings challenge existing paradigms for prolonging antiplatelet therapy after PCI

Lead study investigators from Icahn School of Medicine at Mount Sinai presented their Patterns of Non-Adherence to Anti-Platelet Regimens in Stented Patients (PARIS) study findings at the ESC Congress 2013 in Amsterdam organized by the European Society of Cardiology.

3 Sep 2013

New joint program could improve patient care, physician and staff morale

The common refrain about health care is that it's a broken system. A new joint program between the University of California, Los Angeles and the University of Southern California, demonstrates a way to mend the system with a new patient-centered program that is getting raves from patients, as well as the residents and nurses who provide their care. Results from the program are highlighted in a study being released in September.

3 Sep 2013

Researchers develop first animal model simulating eye complications linked with Graves' disease

Researchers have developed the first animal model simulating the eye complications associated with the thyroid condition Graves' disease, a breakthrough that could pave the way for better treatments, according to a recent study accepted for publication in The Endocrine Society's journal Endocrinology.

3 Sep 2013

Scientists estimate minimum of 320,000 viruses in mammals

Scientists estimate that there is a minimum of 320,000 viruses in mammals awaiting discovery. Collecting evidence of these viruses, or even a majority of them, they say, could provide information critical to early detection and mitigation of disease outbreaks in humans.

3 Sep 2013

Omecamtiv mecarbil fails to achieve primary endpoint in phase II ATOMIC-AHF study

Omecamtiv mecarbil, a cardiac myosin-activator, did not achieve its primary efficacy endpoint in reducing dyspnoea (shortness of breath) in patients with acute heart failure, according to the results of the phase II ATOMIC-AHF (Acute Treatment with Omecamtiv Mecarbil to Increase Contractility in Acute Heart Failure) study.

3 Sep 2013

Researchers examine how online social network activities influence smoking, alcohol use

Teenagers who see friends smoking and drinking alcohol in photographs posted on Facebook and Myspace are more likely to smoke and drink themselves, according to a new study from the University of Southern California (USC).

3 Sep 2013

Study assesses relationship between BMI and CV events in hypertensive patients with diabetes

Low BMI is a risk factor for CVD in hypertensive patients with diabetes, according to research presented at the ESC Congress today by Dr Takanori Nagahiro from Japan. The findings provide evidence for an obesity paradox in hypertensive patients with glucose intolerance.

3 Sep 2013

Medical News

First Edition: September 3, 2013

Apitope successfully completes ATX-MS-1467 Phase I trial in relapsing MS patients with positive results

Prana's PBT2 drug recognised as one of the most promising treatments under development

Imaxio's pro-immunogenic technology used in tuberculosis vaccine phase I clinical study

New NPS MedicineWise educational program highlights medicine-related adverse events in older people

Renin inhibitor aliskiren not effective in slowing progression of coronary atherosclerosis

The Learning Habit Study examines family routines and child's ability to learn

Elsevier publishes position statement by EMAS in journal Maturitas on the topic of late parenthood

Research shows how mucosal surfaces in body respond to C. albicans to prevent damage

Trypophobia: The most common phobia may occur as result of specific visual feature

Findings challenge existing paradigms for prolonging antiplatelet therapy after PCI

New joint program could improve patient care, physician and staff morale

Researchers develop first animal model simulating eye complications linked with Graves' disease

Scientists estimate minimum of 320,000 viruses in mammals

Omecamtiv mecarbil fails to achieve primary endpoint in phase II ATOMIC-AHF study

Researchers examine how online social network activities influence smoking, alcohol use

Study assesses relationship between BMI and CV events in hypertensive patients with diabetes

Acacia Pharma raises $23.5 million in Series B financing

New manual by psychologist explains basics of hypnotherapy

Researchers create specific tests to detect cancer biomarkers in patients with dermatomyositis

Advancing Motor Neuron Disease Diagnosis with Non-Invasive Ultrasound and AI

How agentic AI is reshaping laboratory workflows

Fourier 80: bringing benchtop NMR systems to the laboratory

Latest News